PH12013502219A1 - Humanization of rabbit antibodies using a universal antibody framework - Google Patents
Humanization of rabbit antibodies using a universal antibody frameworkInfo
- Publication number
- PH12013502219A1 PH12013502219A1 PH12013502219A PH12013502219A PH12013502219A1 PH 12013502219 A1 PH12013502219 A1 PH 12013502219A1 PH 12013502219 A PH12013502219 A PH 12013502219A PH 12013502219 A PH12013502219 A PH 12013502219A PH 12013502219 A1 PH12013502219 A1 PH 12013502219A1
- Authority
- PH
- Philippines
- Prior art keywords
- universal antibody
- humanization
- rabbit antibodies
- antibody framework
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
Abstract
The present invention relates to an universal antibody acceptor framework and to methods for grafting non-human antibodies, e.g., rabbit antibodies, using a universal antibody acceptor framework. Antibodies generated by the methods of the invention are useful in a variety of diagnostic and therapeutic applications.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7569208P | 2008-06-25 | 2008-06-25 | |
US7569708P | 2008-06-25 | 2008-06-25 | |
US15510509P | 2009-02-24 | 2009-02-24 | |
US15504109P | 2009-02-24 | 2009-02-24 | |
CH8322009 | 2009-06-02 | ||
PCT/CH2009/000222 WO2009155726A2 (en) | 2008-06-25 | 2009-06-25 | Humanization of rabbit antibodies using a universal antibody framework |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12013502219A1 true PH12013502219A1 (en) | 2016-01-25 |
Family
ID=53532693
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12013502219A PH12013502219A1 (en) | 2008-06-25 | 2013-10-25 | Humanization of rabbit antibodies using a universal antibody framework |
PH12018501715A PH12018501715A1 (en) | 2008-06-25 | 2018-08-13 | Humanization of rabbit antibodies using a universal antibody framework |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12018501715A PH12018501715A1 (en) | 2008-06-25 | 2018-08-13 | Humanization of rabbit antibodies using a universal antibody framework |
Country Status (9)
Country | Link |
---|---|
JP (5) | JP2015120746A (en) |
KR (2) | KR20210097819A (en) |
CL (1) | CL2010001539A1 (en) |
ES (1) | ES2771150T3 (en) |
HU (1) | HUE047678T2 (en) |
PH (2) | PH12013502219A1 (en) |
PT (2) | PT2752428T (en) |
RU (2) | RU2696202C1 (en) |
ZA (3) | ZA201008592B (en) |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000516452A (en) * | 1996-07-16 | 2000-12-12 | プリュックテュン,アンドレアス | Immunoglobulin superfamily domains and fragments with increased solubility |
EA013564B1 (en) * | 2000-08-03 | 2010-06-30 | Терапеутик Хьюман Поликлоналз Инк. | Humanized immunoglobulin and pharmaceutical composition comprising thereof |
AU2002303496A2 (en) * | 2001-04-25 | 2002-11-05 | Weigel, Janet A | Methods of using a hyaluronan receptor |
WO2003074679A2 (en) * | 2002-03-01 | 2003-09-12 | Xencor | Antibody optimization |
US8853362B2 (en) * | 2002-05-22 | 2014-10-07 | Esbatech, An Alcon Biomedical Research Unit Llc | Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
CA2492524A1 (en) | 2002-08-15 | 2004-02-26 | Epitomics, Inc. | Humanized rabbit antibodies |
CA2533830A1 (en) * | 2003-08-07 | 2005-02-24 | Epitomics, Inc. | Methods for humanizing rabbit monoclonal antibodies |
EP1660534A2 (en) * | 2003-08-22 | 2006-05-31 | MedImmune, Inc. | Humanization of antibodies |
US7431927B2 (en) * | 2005-03-24 | 2008-10-07 | Epitomics, Inc. | TNFα-neutralizing antibodies |
EP2390267B1 (en) * | 2005-06-07 | 2013-06-05 | ESBATech - a Novartis Company LLC | Stable and soluble antibodies inhibiting TNF(alpha) |
NZ563370A (en) * | 2005-06-20 | 2010-10-29 | Genentech Inc | Compositions and methods for the diagnosis and treatment of tumor |
GB0520436D0 (en) * | 2005-10-07 | 2005-11-16 | Photobiotics Ltd | Biological materials and uses thereof |
WO2008004834A1 (en) * | 2006-07-06 | 2008-01-10 | Isu Abxis Co., Ltd | Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor |
NZ580245A (en) * | 2007-03-22 | 2012-01-12 | Biogen Idec Inc | Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
-
2009
- 2009-06-25 PT PT141626648T patent/PT2752428T/en unknown
- 2009-06-25 KR KR1020217023841A patent/KR20210097819A/en active Application Filing
- 2009-06-25 PT PT97686950T patent/PT2307458T/en unknown
- 2009-06-25 ES ES14162664T patent/ES2771150T3/en active Active
- 2009-06-25 HU HUE14162664A patent/HUE047678T2/en unknown
- 2009-06-25 KR KR1020197022505A patent/KR102284435B1/en active IP Right Grant
-
2010
- 2010-11-30 ZA ZA2010/08592A patent/ZA201008592B/en unknown
- 2010-12-23 CL CL2010001539A patent/CL2010001539A1/en unknown
-
2013
- 2013-10-25 PH PH12013502219A patent/PH12013502219A1/en unknown
- 2013-11-21 ZA ZA2013/08755A patent/ZA201308755B/en unknown
-
2015
- 2015-03-18 JP JP2015054497A patent/JP2015120746A/en not_active Withdrawn
- 2015-05-11 ZA ZA2015/03267A patent/ZA201503267B/en unknown
-
2016
- 2016-04-27 JP JP2016088845A patent/JP2016135815A/en active Pending
-
2017
- 2017-07-31 JP JP2017148091A patent/JP6568557B2/en active Active
-
2018
- 2018-03-19 RU RU2018109506A patent/RU2696202C1/en active
- 2018-08-13 PH PH12018501715A patent/PH12018501715A1/en unknown
-
2019
- 2019-02-01 JP JP2019016882A patent/JP6903083B2/en active Active
- 2019-06-21 RU RU2019119412A patent/RU2019119412A/en unknown
-
2020
- 2020-04-30 JP JP2020080224A patent/JP2020114260A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
PT2752428T (en) | 2020-02-14 |
RU2696202C1 (en) | 2019-07-31 |
HUE047678T2 (en) | 2020-05-28 |
JP2015120746A (en) | 2015-07-02 |
ZA201308755B (en) | 2015-08-26 |
JP2016135815A (en) | 2016-07-28 |
JP2020114260A (en) | 2020-07-30 |
PH12018501715A1 (en) | 2019-08-19 |
CL2010001539A1 (en) | 2012-02-03 |
JP2017190352A (en) | 2017-10-19 |
ZA201503267B (en) | 2016-07-27 |
JP6903083B2 (en) | 2021-07-14 |
ZA201008592B (en) | 2014-02-26 |
KR102284435B1 (en) | 2021-08-02 |
JP6568557B2 (en) | 2019-08-28 |
KR20190091578A (en) | 2019-08-06 |
JP2019065050A (en) | 2019-04-25 |
KR20210097819A (en) | 2021-08-09 |
ES2771150T3 (en) | 2020-07-06 |
RU2019119412A (en) | 2020-12-21 |
PT2307458T (en) | 2018-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018200640B2 (en) | Humanization of rabbit antibodies using a universal antibody framework | |
CY1126083T1 (en) | RODEN MODELS AND THERAPEUTIC MOLECULES | |
CY1122278T1 (en) | ANTI IL-36R ANTIBODIES | |
PH12015500125A1 (en) | Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof | |
HK1162119A1 (en) | Animal models and therapeutic molecules | |
TN2014000120A1 (en) | Cd27l antigen binding proteins | |
MX2011003855A (en) | Methods for producing antibodies from plasma cells. | |
AU2012222463A8 (en) | Cea antibodies | |
MX353144B (en) | Heterodimeric antibody fc-containing proteins and methods for production thereof. | |
MY162791A (en) | Anti-il-23 antibodies | |
MX2009000520A (en) | Methods for producing fuels and solvents. | |
MX2009008140A (en) | Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells. | |
WO2010039900A3 (en) | Non-human mammals for the production of chimeric antibodies | |
DE602006006200D1 (en) | ANTIBODY AGAINST 25-HYDROXYVITAMINE D | |
GB201108236D0 (en) | Method | |
WO2009052400A8 (en) | Antibodies that bind to mammalian ngal and uses thereof | |
MY161909A (en) | Anti-her3 antibodies and uses thereof | |
BRPI0916915A2 (en) | bispecific cross-reactive anti-il-17a / f antibodies | |
BR112014005644A2 (en) | anti-alphabet antibody | |
MX2009004167A (en) | Antibodies that bind cxcr7 epitopes. | |
SG178886A1 (en) | Humanized anti-cdcp1 antibodies | |
MX337203B (en) | Novel jnk inhibitor molecules. | |
WO2009130459A3 (en) | Epitopes of il-17a and il-17f and antibodies specific thereto | |
PH12018501715A1 (en) | Humanization of rabbit antibodies using a universal antibody framework | |
MX2020010187A (en) | Humanization of rabbit antibodies using a universal antibody framework. |